Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

RBC Capital Maintains Outperform on Stericycle, Lowers Price Target to $58

Author: Benzinga Newsdesk | November 03, 2023 03:28pm
RBC Capital analyst Sean Dodge maintains Stericycle (NASDAQ:SRCL) with a Outperform and lowers the price target from $62 to $58.

Posted In: SRCL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist